About us
LTU School of Cancer Medicine
Our People
Our Partners
Our Corporate Publications
Our Policies
A message from our Founding Champion
Our Research
Research Programs
Cancer and Inflammation Program
Cancer and Inflammation Laboratory
Tumour Microenvironment and Cancer Signaling Group
Cancer Therapeutics Development Group
Cancer Immunobiology Program
Tumour Immunology Laboratory
Mucosal Immunity and Cancer Laboratory
Gastrointestinal Cancer Program
Oncogenic Transcription Laboratory
Cell Death and Survival Laboratory
Translational Breast Cancer Program
Metastasis Research Laboratory
Matrix Microenvironment and Metastasis Laboratory
Tumour Progression and Heterogeneity Laboratory
Cancer Single Cell Genomics Laboratory
Tumour Targeting Program
Tumour Targeting Laboratory
Receptor Biology Laboratory
Centre for Research Excellence in Brain Cancer
Bioinformatics and Cancer Genomics Laboratory
Research Platforms
The ACRF Centre for Translational Cancer Therapeutics and Imaging
The ACRF Centre for Imaging the Tumour Environment
VECTRA Multi-Spectral Imaging Platform
Mammalian Protein Expression Facility
Flow Cytometry Core Facility
Clinical Trials
Latest news
Join our team
Study opportunities
Career opportunities
Volunteer Opportunities
Contact us
Support us
Donate now
Search
Clinical trials
NHMRC funding strengthens biliary cancer research focus
Read More
Rare cancers clinical trial findings to have global benefit for patients
Read More
Rare cancer trial funding boost
Read More
Prof Andrew Scott to lead national brain cancer study
Read More
Clinical Trial of Anti-EphA3 Antibody Enrolls First Brain Cancer Patient
Read More
Taking on aggressive breast cancer with non-cancer drugs
Read More
Virus-antibody combo shows promise for treating advanced melanoma
Read More
New generation melanoma treatment could remove unwanted side effects
Read More
Donors and researchers team up against deadly disease
Read More
Statement regarding Olivia Newton-John
Read More
Privacy Preference Center
Privacy Preferences
